Furthermore, the expression of GD3S was transcriptionally regulated by NF-κB via FOXC2, and high GD3S expression was observed in triple-negative breast cancer (TNBC) or claudin-low breast cancers, which may lead to a poor survival outcome (Sarkar et al., 2015). The gene discussed is NFKB1; the disease is breast carcinoma.